Statistics
Publications
2
Citations
39
H-Index
2
Active since
2023
Affiliations
Andrew Pain is an author at Eli Lilly (United States) specializing in clinical pharmacology, amyloid clearance, and comparative clinical trials.
Publications per year
2023–2025
2
2
1–2 of 2